Northern Trust’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
287,863
+52,327
| +22% | +$265K | ﹤0.01% | 3181 |
|
|
2025
Q1 | $1.33M | Buy |
235,536
+70,515
| +43% | +$398K | ﹤0.01% | 3142 |
|
|
2024
Q4 | $1.43M | Buy |
165,021
+6,250
| +4% | +$54.3K | ﹤0.01% | 3208 |
|
|
2024
Q3 | $1.1M | Buy |
158,771
+115,326
| +265% | +$799K | ﹤0.01% | 3323 |
|
|
2024
Q2 | $269K | Buy |
43,445
+23,938
| +123% | +$148K | ﹤0.01% | 3750 |
|
|
2024
Q1 | $30.8K | Sell |
19,507
-110
| -0.6% | -$174 | ﹤0.01% | 4294 |
|
|
2023
Q4 | $28.8K | Hold |
19,617
| – | – | ﹤0.01% | 4328 |
|
|
2023
Q3 | $18K | Hold |
19,617
| – | – | ﹤0.01% | 4345 |
|
|
2023
Q2 | $24.7K | Hold |
19,617
| – | – | ﹤0.01% | 4369 |
|
|
2023
Q1 | $26.5K | Buy |
19,617
+5,134
| +35% | +$6.93K | ﹤0.01% | 4400 |
|
|
2022
Q4 | $25.9K | Hold |
14,483
| – | – | ﹤0.01% | 4433 |
|
|
2022
Q3 | $45K | Hold |
14,483
| – | – | ﹤0.01% | 4345 |
|
|
2022
Q2 | $47K | Buy |
14,483
+1,028
| +8% | +$3.34K | ﹤0.01% | 4426 |
|
|
2022
Q1 | $68K | Hold |
13,455
| – | – | ﹤0.01% | 4454 |
|
|
2021
Q4 | $105K | Buy |
+13,455
| New | +$105K | ﹤0.01% | 4401 |
|